Skip to main content
OSG
NYSE Finance

Octave 10-Q: Q3 Revenue Up 28% to $85.3M, Net Loss Narrows to $(13.8)M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Positive
Importance info
7
Price
$5.27
Mkt Cap
$237.421M
52W Low
$3.88
52W High
$10.38
52W Position info
36% above low
Off High info
49% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

OSG sits 36% above its 52-week low of $3.88.

Summary

Octave's Q3 10-Q shows revenue up 28% to $85.3 million and the net loss narrowing to $(13.8) million, with the Specialty P&C segment turning profitable even as management warned of a softening market into 2027.


Key Events · Earnings and Guidance · OSG

  • Q3 Revenue Jumps 28%

    Total revenue rose to $85.3 million from $66.6 million a year ago, led by 35% growth in Insurance Distribution.

  • Net Loss Narrows Sharply

    Net loss attributable to shareholders was $(13.8) million versus $(112.6) million a year ago, which included the discontinued Ambac business.

  • Specialty P&C Turns Profitable

    The segment posted $1.4 million pretax income versus a $(0.05) million loss, with the combined ratio improving to 100.6% from 112.9%.

  • Debt Rises on NCI Buyout

    Long-term debt climbed to $154.8 million from $117.6 million after a $40 million April 2026 term loan add-on used to fund the redeemable NCI purchase.


Analysis · OSG · Finance

The full 10-Q confirms the turnaround the headline release hinted at: revenue of $85.3 million (up 28%) and a net loss to shareholders of $(13.8) million versus $(112.6) million a year ago, which was inflated by the discontinued Ambac business. The real story is segment-level — Specialty P&C swung to a $1.4 million pretax profit with a 100.6% combined ratio, and Insurance Distribution grew 35%. Against that, management flagged a softening P&C market into 2027, and debt rose to $154.8 million after a $40 million borrowing to buy out minority holders. The quarter shows the reshaped insurance-only company approaching breakeven, but the softening pricing cycle is the risk to watch.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OSG was trading at $5.27 on NYSE in the Finance sector, with a market capitalization of approximately $237.4M. The 52-week trading range was $3.88 to $10.38. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OSG - Latest Insights

OSG
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $5.27
Real-time Price: $5.27 info
Change: $0 (0%) info
Market Cap: $237.421M info
OSG
Oct 23, 2026, 8:30 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.72
Real-time Price: $5.27 info
Change: +$0.550 (+12%) info
Market Cap: $237.421M info
OSG
Aug 06, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.89
Real-time Price: $5.27 info
Change: -$0.620 (-11%) info
Market Cap: $237.421M info
OSG
Aug 06, 2026, 4:58 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.89
Real-time Price: $5.27 info
Change: -$0.620 (-11%) info
Market Cap: $237.421M info
OSG
May 14, 2026, 4:14 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $5.69
Real-time Price: $5.27 info
Change: -$0.420 (-7%) info
Market Cap: $237.421M info